21 completed, 3 unknown, 1 terminated. 14 Phase 4, 9 Phase 2, 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 14 | Completed 12, Unknown 2 |
| Phase 2 | 9 | Completed 8, Terminated 1 |
| Phase 3 | 7 | Completed 5, Terminated 1, Unknown 1 |
Follow Flanders Medical Research Program: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions LEGFLOW DCB - Peripheral Arterial Disease | Phase 3 | Unknown | Flanders Medical Research Program | 120 | 2015-10-01 | 2018-08-13 |
| a Physician-inititated Trial Investigating the iVolution Nitinol Stent iVolution nitinol stent - Peripheral Arterial Disease | Phase 2 / Phase 3 | Completed | Flanders Medical Research Program | 120 | 2015-04-01 | 2018-08-13 |
| Clear-Road Trial, Investigating the Efficacy of the RoadSaver Stent RoadSaver stent - Peripheral Arterial Disease | Phase 2 / Phase 3 | Completed | Flanders Medical Research Program | 100 | 2015-04-01 | 2017-08-01 |
| BeSmooth Study, Investigating the BeSmooth Peripheral Stent System for the Treatment of Iliac Lesions BeSmooth peripheral stent - Peripheral Arterial Disease | Phase 4 | Completed | Flanders Medical Research Program | 70 | 2014-10-01 | 2017-01-12 |
| The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions Zilver PTX, prosthetic bypass - Peripheral Vascular Disease | Phase 4 | Unknown | Flanders Medical Research Program | 220 | 2014-08-01 | 2018-03-06 |
| Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion Rotarex S - Peripheral Vascular Disease | Phase 4 | Completed | Flanders Medical Research Program | 30 | 2014-08-01 | 2017-08-01 |
| Physician-Initiated Trial Investigating the BeGraft Peripheral Stent Graft System BeGraft Peripheral Stent Graft System - Peripheral Vascular Disease | Phase 4 | Completed | Flanders Medical Research Program | 70 | 2014-06-01 | 2017-01-12 |
| Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease With the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing With 4EVER Trial Results) Passeo-18 balloon, Passeo-18 Lux drug releasing balloon, Pulsar-18 stent - Peripheral Vascular Disease | Phase 4 | Completed | Flanders Medical Research Program | 120 | 2014-06-01 | 2018-08-13 |
| In.Pact Flexion, Investigating the Performance of the In.Pact Admiral DEB for Popliteal Lesions InPact Admiral DEB - Peripheral Arterial Disease | Phase 4 | Unknown | Flanders Medical Research Program | 100 | 2014-04-01 | 2018-08-13 |
| NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions NanoCross .014 balloon catheter - Peripheral Arterial Disease | Phase 4 | Completed | Flanders Medical Research Program | 100 | 2013-01-01 | 2016-08-11 |
| PREVENT: Promus BTK Everolimus-Eluting Stent (PROMUS ELEMENT) - Peripheral Arterial Disease | Phase 2 | Completed | Flanders Medical Research Program | 70 | 2012-08-01 | 2016-08-11 |
| Single Arm Study With a Nitinol Self-Expanding Paclitaxel-Eluting Stent to Treat BTK Arteries Self-expandable drug eluting stent - Peripheral Arterial Disease | Phase 2 / Phase 3 | Completed | Flanders Medical Research Program | 70 | 2012-01-01 | 2015-03-09 |
| Drug Eluting Stents In The Critically Ischemic Lower Leg 2 stent - Peripheral Arterial Disease | Phase 2 / Phase 3 | Completed | Flanders Medical Research Program | 60 | 2011-07-01 | 2015-03-09 |
| DURABILITY+ : a Prospective, Multi-center, Controlled Study With the Everflex+ Stent in SFA Lesions stent placement - Peripheral Arterial Disease | Phase 4 | Completed | Flanders Medical Research Program | 60 | 2011-05-01 | 2013-10-01 |
| 4-EVER : a Trial Investigating the Safety of 4F Endovascular Treatment of Infra-Inguinal Arterial Stenotic Disease 4F portfolio products from Biotronik - Peripheral Vascular Disease, Claudication | Phase 4 | Completed | Flanders Medical Research Program | 120 | 2010-07-01 | 2013-10-01 |
| Efficacity Study With the Protégé EverFlex Stent in Popliteal Lesions nitinol stent - Peripheral Arterial Disease | Phase 4 | Completed | Flanders Medical Research Program | 60 | 2010-07-01 | 2013-10-01 |
| GORE VIABAHN® Versus Plain Old Balloon Angioplasty (POBA) for Superficial Femoral Artery (SFA) In-Stent Restenosis GORE VIABAHN® Endoprosthesis, Plain old balloon angioplasty - Peripheral Vascular Disease | Phase 4 | Completed | Flanders Medical Research Program | 100 | 2010-05-01 | 2014-09-03 |
| Misago Iliac Study Misago (stent placement) - Vascular Lesions | Completed | Flanders Medical Research Program | 100 | 2010-01-01 | 2014-08-06 | |
| Efficacy Study of Iliac Stents to Treat TASC A-B-C-D Iliac Artery Lesions iliac stenting - Peripheral Vascular Disease, Intermittent Claudication | Phase 4 | Completed | Flanders Medical Research Program | 325 | 2008-12-01 | 2013-01-25 |
| EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study Spectranetics Turbo elite™ excimer laser catheter - Peripheral Arterial Occlusive Disease | Phase 2 / Phase 3 | Terminated | Flanders Medical Research Program | 14 | 2008-07-01 | 2015-03-09 |
Showing 20 of 25. Sign in to see all of them.
Peripheral Arterial Disease (12) · Peripheral Vascular Diseases (9) · Chronic Limb-Threatening Ischemia (5) · Intermittent Claudication (4) · Peripheral Arterial Occlusive Disease 1 (3) · Bites and Stings (1)
Stents (1)
Belgium (25) · Germany (8) · Australia (1) · Austria (1) · France (1) · Netherlands (1) · New Zealand (1)
Marc Bosiers, MD (15) · Koen Deloose, MD (2) · Patrick Peeters, MD (2) · Dierk Scheinert, MD (1) · Evelyn Diessel, PhD (1) · Frank Vermassen, MD (1) · Vladimir Borovicanin, MD (1)
PMID 20354489, PMID 21636239, PMID 22169682, PMID 24325689, PMID 25775672, PMID 28351310, PMID 31997715, PMID 32873131, PMID 37162238